Hypoxia? NNoT a PROblem!
Nicotinamide nucleotide transhydrogenase (NNT) enables glioma cells to sustain growth under hypoxia by linking NADH oxidation to NADPH production, supporting proline synthesis.
- Why it matters: Understanding how cancer cells adapt to hypoxic stress is crucial because tumor regions often experience low oxygen, limiting mitochondrial function and redox balance, which can hinder tumor growth and survival.
- What they did: Vettore and colleagues used molecular cell techniques to demonstrate that NNT is essential for maintaining redox homeostasis in glioma cells under hypoxia by facilitating NADPH generation.
- The result: This discovery reveals NNT-dependent metabolism as a potential vulnerability in hypoxic tumors, offering a new target for therapeutic intervention in glioma treatment.